Back to today’s briefing

Story perspectives

Documentary Uncovers Controversy Behind Addyi's FDA Approval

3/6/2026

35 5 Full Breakdown

Summary

Story summary

The documentary 'The Pink Pill: Sex, Drugs & Who Has Control' explores Addyi's path to FDA approval and labeling.
Addyi began as an antidepressant and was repurposed to treat low libido with FDA approval in 2015.
Addyi carries a 'black box' warning for serious side effects with alcohol.
The film features stories from women with hypoactive sexual desire disorder (HSDD) and critiques attitudes toward female sexual health.

1 of 1

Story summary

The documentary 'The Pink Pill: Sex, Drugs & Who Has Control' explores Addyi's path to FDA approval and labeling.
Addyi began as an antidepressant and was repurposed to treat low libido with FDA approval in 2015.
Addyi carries a 'black box' warning for serious side effects with alcohol.
The film features stories from women with hypoactive sexual desire disorder (HSDD) and critiques attitudes toward female sexual health.